...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Validation of the Antidiabetic and Hypolipidemic Effects ofClitocybe nudaby Assessment of Glucose Transporter 4 and Gluconeogenesis and AMPK Phosphorylation in Streptozotocin-Induced Mice
【24h】

Validation of the Antidiabetic and Hypolipidemic Effects ofClitocybe nudaby Assessment of Glucose Transporter 4 and Gluconeogenesis and AMPK Phosphorylation in Streptozotocin-Induced Mice

机译:通过评估葡萄糖转运蛋白4,链脲佐菌素诱导的小鼠的糖原生成和AMPK磷酸化,验证核糖胞菌的抗糖尿病和降血脂作用

获取原文

摘要

The study was designed to investigate the effects of extract ofClitocybe nuda(CNE) on type 1 diabetes mellitus and dyslipidemia in streptozotocin- (STZ-) induced diabetic mice. Diabetes was induced by injection of STZ. Diabetic mice were randomly divided into five groups and given orally CNE (C1: 0.2, C2: 0.5, and C3: 1.0 g/kg body weight) or metformin (Metf) or vehicle for 4 weeks. STZ induction decreased in the levels of insulin, body weight, and the weight of skeletal muscle, whereas the levels of blood glucose, hemoglobin nonenzymatically (percent HbA1c), and circulating triglyceride (P< 0.001,P< 0.001, andP< 0.01, resp.) were increased. CNE decreased the levels of blood glucose, HbA1c, and triglyceride levels, whereas it increased the levels of insulin and leptin compared with the vehicle-treated STZ group. STZ induction caused a decrease in the protein contents of skeletal muscular and hepatic phosphorylation of AMP-activated protein kinase (phospho-AMPK) and muscular glucose transporter 4 (GLUT4). Muscular phospho-AMPK contents were increased in C2-, C3-, and Metf-treated groups. CNE and Metf significantly increased the muscular proteins of GLUT4. Liver phospho-AMPK showed an increase in all CNE- and Metf-treated groups combined with the decreased hepatic glucose production by decreasing phosphenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), and 11beta hydroxysteroid dehydroxygenase (11β-HSD1) gene, which contributed to attenuating diabetic state. The study indicated that the hypoglycemic properties of CNE were related to both the increased muscular glucose uptake and the reduction in hepatic gluconeogenesis. CNE exerts hypolipidemic effect by increasing gene expressions of peroxisome proliferator-activated receptorα(PPARα) and decreasing expressions of fatty acid synthesis, including acyl-coenzyme A: diacylglycerol acyltransferase (DGAT) 2. Therefore, amelioration of diabetic and dyslipidemic state by CNE in STZ-induced diabetic mice occurred by regulation of GLUT4, PEPCK, DGAT2, and AMPK phosphorylation.
机译:这项研究旨在调查链球菌提取物(CNE)对链脲佐菌素(STZ-)诱导的糖尿病小鼠的1型糖尿病和血脂异常的影响。注射STZ可诱发糖尿病。糖尿病小鼠随机分为五组,口服CNE(C1:0.2,C2:0.5和C3:1.0μg/ kg体重)或二甲双胍(Metf)或赋形剂治疗4周。 STZ诱导的胰岛素,体重和骨骼肌重量降低,而血糖,非酶促血红蛋白水平(HbA1c百分比)和循环甘油三酸酯水平降低(P <0.001,P <0.001和P <0.01) 。)增加了。与媒介物治疗的STZ组相比,CNE降低了血糖,HbA1c和甘油三酸酯的水平,但增加了胰岛素和瘦素的水平。 STZ诱导导致AMP激活的蛋白激酶(phospho-AMPK)和肌肉葡萄糖转运蛋白4(GLUT4)的骨骼肌和肝磷酸化蛋白含量降低。在C2-,C3-和Metf处理组中,肌肉磷酸AMPK含量增加。 CNE和Metf显着增加了GLUT4的肌肉蛋白。肝脏磷酸化AMPK在所有经CNE和Metf治疗的组中均增加,并通过减少磷酸酚丙酮酸羧激酶(PEPCK),葡萄糖6磷酸酶(G6Pase)和11β羟类固醇脱羟基酶(11β-HSD1)基因减少了肝葡萄糖的产生,这有助于减弱糖尿病状态。研究表明,CNE的降血糖特性与增加的肌肉葡萄糖摄取和肝糖异生的减少有关。 CNE通过增加过氧化物酶体增殖物激活受体α(PPARα)的基因表达和降低脂肪酸合成的表达(包括酰基辅酶A:二酰基甘油酰基转移酶(DGAT)2)发挥降血脂作用。因此,CNE可改善STZ的糖尿病和血脂异常状态。诱导的糖尿病小鼠通过调节GLUT4,PEPCK,DGAT2和AMPK磷酸化而发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号